The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59

The relationship between Canadian mammography screening practices for women 40–49 and breast cancer (BC) stage at diagnosis in women 40–49 and 50–59 years was assessed using data from the Canadian Cancer Registry, provincial/territorial screening practices, and screening information from the Canadia...

Full description

Bibliographic Details
Main Authors: Anna N. Wilkinson, Jean-Michel Billette, Larry F. Ellison, Michael A. Killip, Nayaar Islam, Jean M. Seely
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Current Oncology
Subjects:
Online Access:https://www.mdpi.com/1718-7729/29/8/444
_version_ 1797432284447506432
author Anna N. Wilkinson
Jean-Michel Billette
Larry F. Ellison
Michael A. Killip
Nayaar Islam
Jean M. Seely
author_facet Anna N. Wilkinson
Jean-Michel Billette
Larry F. Ellison
Michael A. Killip
Nayaar Islam
Jean M. Seely
author_sort Anna N. Wilkinson
collection DOAJ
description The relationship between Canadian mammography screening practices for women 40–49 and breast cancer (BC) stage at diagnosis in women 40–49 and 50–59 years was assessed using data from the Canadian Cancer Registry, provincial/territorial screening practices, and screening information from the Canadian Community Health Survey. For the 2010 to 2017 period, women aged 40–49 were diagnosed with lesser relative proportions of stage I BC (35.7 vs. 45.3%; <i>p</i> < 0.001), but greater proportions of stage II (42.6 vs. 36.7%, <i>p</i> < 0.001) and III (17.3 vs. 13.1%, <i>p</i> < 0.001) compared to women 50–59. Stage IV was lower among women 40–49 than 50–59 (4.4% vs. 4.8%, <i>p</i> = 0.005). Jurisdictions with organised screening programs for women 40–49 with annual recall (screeners) were compared with those without (comparators). Women aged 40–49 in comparator jurisdictions had higher proportions of stages II (43.7% vs. 40.7%, <i>p</i> < 0.001), III (18.3% vs. 15.6%, <i>p</i> < 0.001) and IV (4.6% vs. 3.9%, <i>p</i> = 0.001) compared to their peers in screener jurisdictions. Based on screening practices for women aged 40–49, women aged 50–59 had higher proportions of stages II (37.2% vs. 36.0%, <i>p</i> = 0.003) and III (13.6% vs. 12.3%, <i>p</i> < 0.001) in the comparator versus screener groups. The results of this study can be used to reassess the optimum lower age for BC screening in Canada.
first_indexed 2024-03-09T09:58:09Z
format Article
id doaj.art-3a28d12cee8c48f1b8f94050a4c26109
institution Directory Open Access Journal
issn 1198-0052
1718-7729
language English
last_indexed 2024-03-09T09:58:09Z
publishDate 2022-08-01
publisher MDPI AG
record_format Article
series Current Oncology
spelling doaj.art-3a28d12cee8c48f1b8f94050a4c261092023-12-01T23:35:33ZengMDPI AGCurrent Oncology1198-00521718-77292022-08-012985627564310.3390/curroncol29080444The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59Anna N. Wilkinson0Jean-Michel Billette1Larry F. Ellison2Michael A. Killip3Nayaar Islam4Jean M. Seely5Department of Family Medicine, Faculty of Medicine, University of Ottawa, Ottawa, ON K1H 8L6, CanadaCentre for Population Health Data at Statistics Canada, Ottawa, ON K1A 0T6, CanadaCentre for Population Health Data at Statistics Canada, Ottawa, ON K1A 0T6, CanadaSchool of Medicine, University of Limerick, V94 T9PX Limerick, IrelandClinical Epidemiology Program, The Ottawa Hospital Research Institute, Ottawa, ON K1H 8L6, CanadaDepartment of Radiology, The Ottawa Hospital Research Institute, University of Ottawa, Ottawa, ON K1H 8L6, CanadaThe relationship between Canadian mammography screening practices for women 40–49 and breast cancer (BC) stage at diagnosis in women 40–49 and 50–59 years was assessed using data from the Canadian Cancer Registry, provincial/territorial screening practices, and screening information from the Canadian Community Health Survey. For the 2010 to 2017 period, women aged 40–49 were diagnosed with lesser relative proportions of stage I BC (35.7 vs. 45.3%; <i>p</i> < 0.001), but greater proportions of stage II (42.6 vs. 36.7%, <i>p</i> < 0.001) and III (17.3 vs. 13.1%, <i>p</i> < 0.001) compared to women 50–59. Stage IV was lower among women 40–49 than 50–59 (4.4% vs. 4.8%, <i>p</i> = 0.005). Jurisdictions with organised screening programs for women 40–49 with annual recall (screeners) were compared with those without (comparators). Women aged 40–49 in comparator jurisdictions had higher proportions of stages II (43.7% vs. 40.7%, <i>p</i> < 0.001), III (18.3% vs. 15.6%, <i>p</i> < 0.001) and IV (4.6% vs. 3.9%, <i>p</i> = 0.001) compared to their peers in screener jurisdictions. Based on screening practices for women aged 40–49, women aged 50–59 had higher proportions of stages II (37.2% vs. 36.0%, <i>p</i> = 0.003) and III (13.6% vs. 12.3%, <i>p</i> < 0.001) in the comparator versus screener groups. The results of this study can be used to reassess the optimum lower age for BC screening in Canada.https://www.mdpi.com/1718-7729/29/8/444breast cancerscreening mammographystage shiftregistriespreventionrecommendations
spellingShingle Anna N. Wilkinson
Jean-Michel Billette
Larry F. Ellison
Michael A. Killip
Nayaar Islam
Jean M. Seely
The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
Current Oncology
breast cancer
screening mammography
stage shift
registries
prevention
recommendations
title The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
title_full The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
title_fullStr The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
title_full_unstemmed The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
title_short The Impact of Organised Screening Programs on Breast Cancer Stage at Diagnosis for Canadian Women Aged 40–49 and 50–59
title_sort impact of organised screening programs on breast cancer stage at diagnosis for canadian women aged 40 49 and 50 59
topic breast cancer
screening mammography
stage shift
registries
prevention
recommendations
url https://www.mdpi.com/1718-7729/29/8/444
work_keys_str_mv AT annanwilkinson theimpactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT jeanmichelbillette theimpactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT larryfellison theimpactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT michaelakillip theimpactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT nayaarislam theimpactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT jeanmseely theimpactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT annanwilkinson impactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT jeanmichelbillette impactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT larryfellison impactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT michaelakillip impactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT nayaarislam impactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059
AT jeanmseely impactoforganisedscreeningprogramsonbreastcancerstageatdiagnosisforcanadianwomenaged4049and5059